Results 111 to 120 of about 48,845 (222)
ABSTRACT Background Advances in hematology‐oncology have substantially improved survival among patients with cancer. However, longer survival has been accompanied by an increasing burden of cancer therapy‐related cardiovascular toxicity (CTR‐CVT), which contributes to overall morbidity and mortality among cancer survivors.
Philippe Attieh +6 more
wiley +1 more source
Sunitinib-induced thyrotoxicosis - a not so rare entity
Background/Aim: The tyrosine kinase inhibitor (TKI) sunitinib malate is nowadays a standard first-line treatment option for patients with metastatic clear-cell renal cell carcinoma (mRCC).
Jazvić, Marijana +8 more
core +1 more source
The Effect of Adenosine Triphosphate on Oral Mucosity in Rats due to Sunitinib Administration
Sunitinib, a common drug used in cancer treatment, is a multi-targeted tyrosine kinase inhibitor. It is argued that sunitinib-associated oral mucositis is caused by VEGF inhibition.
Suleyman, Halis +9 more
core
Lysosomes play a key role in the accumulation, catabolism, and transport of endogenous and exogenous metabolites and proteins and are involved in drug metabolism and prodrug activation. However, the protein abundance and interindividual variability of lysosomal drug‐metabolizing enzymes and transporters (DMETs) remain underexplored.
Darshak Gadara +20 more
wiley +1 more source
Sunitinib, a first-line tyrosine kinase inhibitor, is widely used for renal cell carcinoma (RCC) therapy; however, sunitinib resistance compromises clinical efficacy. N6-methyladenosine (m6A), the most prevalent internal RNA modification, plays a crucial
Cheng Xu +5 more
doaj +1 more source
Abstract Objectives Sodium is increasingly recognised as a modulator of immune function, and higher baseline serum sodium has been linked to improved outcomes with immune checkpoint inhibitor (IO)‐based therapy in post hoc analyses of randomised trials.
Alix Tschirhart +18 more
wiley +1 more source
This graphical abstract summarizes the inhibitory effect of Yigong San (YGS) on gastric cancer proliferation and the underlying mechanisms. UPLC‐MS/MS identified the active components of YGS, thereby providing a basis for its pharmacological effects.
Doudou Lu +8 more
wiley +1 more source
ABSTRACT Introduction Renal cell carcinoma (RCC) is the most common primary site of pancreatic metastases, and complete resection confers a favorable prognosis. Lenvatinib plus pembrolizumab (LEN + PEM) is standard first‐line therapy for advanced RCC; however, induction therapy before resection of pancreatic metastasis has not been reported.
Yuta Kaneko +9 more
wiley +1 more source
ABSTRACT Introduction Data on cabozantinib monotherapy for metastatic renal cell carcinoma in patients requiring hemodialysis are scarce. We present two cases: initiation before hemodialysis with subsequent continuation and initiation during maintenance hemodialysis.
Taketoshi Nara +6 more
wiley +1 more source
Sunitinib malate induces cell death in adult human cardiac progenitor cells
Sunitinib malate is known to cause cardiotoxicity in a sub-population of patients, with heart failure seen in more severe cases. Cardiac progenitor cells (CPCs) have been identified in adult human myocardium and contribute to overall tissue maintenance ...
Robert Walmsley +3 more
doaj +1 more source

